Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia
Open Access
- 3 December 2011
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 87 (3) , 323-326
Abstract
Intensive consolidation chemotherapy for acute myeloid leukemia (AML) patients in complete remission is being increasingly administered on an outpatient basis. Although this approach has been found to be safe and feasible in younger patients, its safety in older patients remains unknown. We therefore undertook an evaluation of outpatient-based consolidation chemotherapy in older AML patients, and compared results to younger patients treated at the same institution over the same time period. The overall rate of readmission was ~50%, mostly for infections, with mean admission duration of 2 weeks. The overall mortality rate was 2.2%. Readmission rates and duration of readmission were somewhat higher in older patients, but infection rate, intensive care (ICU) admissions, and mortality rates were comparable to those in the younger patient cohort. However, we also observed that rates of febrile neutropenia, bacteremia, ICU admission, and death were significantly higher during the second consolidation, as compared with the first, in both younger and older patients. We conclude that outpatient-based consolidation therapy can be safely undertaken in a substantial proportion of fit older patients with AML.Keywords
This publication has 16 references indexed in Scilit:
- Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistanceLeukemia & Lymphoma, 2010
- Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemiaEuropean Journal of Haematology, 2010
- Outpatient Management of Acute Myeloid Leukemia after Intensive Consolidation Chemotherapy Is Feasible and Reduces Hospital Treatment CostsOnkologie, 2010
- Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemiaAnnals of Oncology, 2007
- Shifting to outpatient management of acute myeloid leukemia: a prospective experienceAnnals of Oncology, 2006
- Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and NeutropeniaNew England Journal of Medicine, 2005
- Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Outpatient Supportive Care Following Chemotherapy for Acute Myeloblastic LeukemiaLeukemia & Lymphoma, 2001
- Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First RemissionNew England Journal of Medicine, 1998
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994